43 /100
MEDIUM RISK
Score updated Jul 15, 2026

XNDU — Xanadu Quantum Technologies Limited Dilution Risk Tracker

Track XNDU dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track XNDU — Get alerts when the score changes →

As of July 15, 2026, Xanadu Quantum Technologies Limited (XNDU) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. Xanadu Quantum Technologies Limited has a market capitalization of $5.10B, 1 shares outstanding, 10 institutional holders tracked.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration 15%
• Score climbed 7 points (worsening)
🔔 Track XNDU — Get forecast alerts →

💹 Market Data

Market Cap$5.10B
Shares Outstanding1
FloatN/A
Cash$272.46M
Debt$30.03M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 17.36M shares
#1 MMCAP International, Inc. SPC 6.88M shares
#2 StepStone Group LP 3.42M shares
#3 Polar Asset Management Partners Inc. 2.00M shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest5.44M
Days to Cover1.4
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

EFFECT EFFECT Jun 01, 2026
EFFECT EFFECT May 01, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
Full SEC filing analysis available with free account

📰 Recent News

📋 What This Means for XNDU Shareholders

Xanadu Quantum Technologies Limited (XNDU) has a DilutionScore of 43/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 15, 2026.

DilutionWatch's EDGAR monitoring for XNDU shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for XNDU in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for XNDU alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track XNDU Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking XNDU — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for XNDU
📊 XNDU FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 XNDU Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.